Table 3.
Antidepressant | Count | Percentage of sample endorsing |
Sertraline | 9132 | 44.12 |
Escitalopram | 7076 | 34.19 |
Venlafaxine | 6287 | 30.38 |
Fluoxetine | 5823 | 28.14 |
Citalopram | 4060 | 19.62 |
Desvenlafaxine | 4042 | 19.53 |
Duloxetine | 3168 | 15.31 |
Mirtazapine | 3134 | 15.14 |
Amitriptyline | 2593 | 12.53 |
Paroxetine | 2471 | 11.94 |
Other | 2212 | 10.69 |
Fluvoxamine | 793 | 3.83 |
Moclobemide | 491 | 2.37 |
Dothiepin | 448 | 2.16 |
Nortriptyline | 345 | 1.67 |
Reboxetine | 341 | 1.65 |
Imipramine | 322 | 1.56 |
Doxepin | 287 | 1.39 |
Clomipramine | 228 | 1.1 |
Tranylcypromine | 212 | 1.02 |
Phenelzine | 146 | 0.71 |
Mianserin | 86 | 0.42 |
Never taken antidepressants | 976 | 4.72 |
Participants may report taking more than one antidepressant.
AGDS, Australian Genetics of Depression Study.